|
·
|
Total revenue for the third quarter of 2010 was $2.2 million, as compared to $1.4 million for the quarter ended September 30, 2009, reflecting a significant increase in product revenue.
|
|
·
|
Operating expense was $3.5 million for the third quarter of 2010, as compared to $3.2 million for the quarter ended September 30, 2009. The increase was due to additional investments in engineering to develop new products in the Unified Communications (UC) and Virtual Desktop Infrastructure (VDI) markets, offset by a decrease in severance-related general and administrative expenses.
|
|
·
|
Net loss in the third quarter of 2010 was $1.5 million, or $0.04 per basic and diluted share, as compared to a net loss of $1.9 million, or $0.05 per share, in the third quarter of 2009.
|
|
·
|
Cash and cash equivalents balance as of September 30, 2010 was $354,000. Cash generated from operations during the nine months ended September 30, 2010 was $5.5 million, compared to cash used in operations of $4.3 million for the nine months ended September 30, 2009.
|
|
·
|
Adjusted EBITDA profit (as described below) for the nine months ended September 30, 2010 was $7.4 million compared to an adjusted EBITDA loss of $541,000 for the same period in 2009.
|
|
·
|
Avistar’s total debt balance was $6.0 million on September 30, 2010, a significant reduction from $11.3 million at December 31, 2009.
|
|
·
|
Avistar continues to deliver advanced visual communications software components and solutions to industry leading UC and VDI providers such as IBM, LifeSize and Logitech. This includes recent products initiatives such as LifeSize Communicator.
|
|
·
|
The Avistar C3 Integrator™ solution continues to provide exclusive desktop videoconferencing support for leading VDI solutions such as Citrix XenDesktop and now Citrix XenApp 5 and 6.
|
|
·
|
Avistar lunched the industry’s largest unified visual communications installation with more than 30,000 Avistar C3 Unified™ – Microsoft OCS Edition endpoints being deployed at a top tier global banking institution.
|
|
Elias MurrayMetzger
Chief Financial Officer
Avistar Communications Corporation
+1 650-525-3300
emurraymetzger@avistar.com
|
Conway Communications
Investor Relations
+1 617-244-9682
maryconway@comcast.net
|
|
Three Months Ended September 30,
|
Nine Months Ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Revenue:
|
||||||||||||||||
|
Product
|
$ | 1,249 | $ | 289 | $ | 1,640 | $ | 3,235 | ||||||||
|
Licensing and sale of patents
|
379 | 350 | 14,736 | 572 | ||||||||||||
|
Services, maintenance and support
|
609 | 790 | 1,659 | 3,130 | ||||||||||||
|
Total revenue
|
2,237 | 1,429 | 18,035 | 6,937 | ||||||||||||
|
Costs and expenses:
|
||||||||||||||||
|
Cost of product revenues*
|
131 | 263 | 369 | 926 | ||||||||||||
|
Cost of services, maintenance and support revenues*
|
387 | 737 | 1,053 | 2,400 | ||||||||||||
|
Income from settlement and patent licensing
|
- | (1,057 | ) | - | (3,171 | ) | ||||||||||
|
Research and development*
|
1,579 | 891 | 5,083 | 2,777 | ||||||||||||
|
Sales and marketing*
|
739 | 629 | 2,048 | 1,992 | ||||||||||||
|
General and administrative*
|
1,143 | 1,709 | 3,280 | 4,143 | ||||||||||||
|
Total costs and expenses
|
3,979 | 3,172 | 11,833 | 9,067 | ||||||||||||
|
Income (loss) from operations
|
(1,742 | ) | (1,743 | ) | 6,202 | (2,130 | ) | |||||||||
|
Other income (expense), net
|
(20 | ) | (126 | ) | (37 | ) | (358 | ) | ||||||||
|
Income (loss) before provision for (benefit from) income taxes
|
(1,762 | ) | (1,869 | ) | 6,165 | (2,488 | ) | |||||||||
|
Provision for (benefit from) income taxes
|
(262 | ) | 16 | (163 | ) | (37 | ) | |||||||||
|
Net income (loss)
|
$ | (1,500 | ) | $ | (1,885 | ) | $ | 6,328 | $ | (2,451 | ) | |||||
|
Net income (loss) per share - basic and diluted
|
$ | (0.04 | ) | $ | (0.05 | ) | $ | 0.16 | $ | (0.07 | ) | |||||
|
Weighted average shares used in calculating
|
||||||||||||||||
|
basic net income (loss) per share
|
39,090 | 38,970 | 39,040 | 36,759 | ||||||||||||
|
Weighted average shares used in calculating
|
||||||||||||||||
|
diluted net income (loss) per share
|
39,090 | 38,970 | 39,572 | 36,759 | ||||||||||||
|
*Including stock based compensation of:
|
||||||||||||||||
|
Cost of products, services, maintenance and support revenue
|
$ | 15 | $ | 53 | $ | 31 | $ | 175 | ||||||||
|
Research and development
|
86 | 110 | 288 | 435 | ||||||||||||
|
Sales and marketing
|
67 | 48 | 152 | 155 | ||||||||||||
|
General and administrative
|
241 | 218 | 524 | 642 | ||||||||||||
| $ | 409 | $ | 429 | $ | 995 | $ | 1,407 | |||||||||
|
September 30,
|
December 31,
|
|||||||
|
2010
|
2009
|
|||||||
|
(unaudited)
|
||||||||
|
Assets:
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 354 | $ | 294 | ||||
|
Accounts receivable, net of allowance for doubtful accounts of $9 and $13 at September 30, 2010 and December 31, 2009, respectively
|
1,556 | 1,027 | ||||||
|
Inventories
|
29 | 56 | ||||||
|
Prepaid expenses and other current assets
|
692 | 300 | ||||||
|
Total current assets
|
2,631 | 1,677 | ||||||
|
Property and equipment, net
|
195 | 147 | ||||||
|
Other assets
|
133 | 132 | ||||||
|
Total assets
|
$ | 2,959 | $ | 1,956 | ||||
|
Liabilities and Stockholders' Equity (Deficit):
|
||||||||
|
Current liabilities:
|
||||||||
|
Line of credit
|
$ | 6,000 | $ | 11,250 | ||||
|
Accounts payable
|
806 | 807 | ||||||
|
Deferred services revenue and customer deposits
|
1,163 | 2,008 | ||||||
|
Income taxes payable
|
80 | 23 | ||||||
|
Accrued liabilities and other
|
1,105 | 1,409 | ||||||
|
Total current liabilities
|
9,154 | 15,497 | ||||||
|
Long-term liabilities:
|
||||||||
|
Other long-term liabilities
|
51 | 73 | ||||||
|
Total liabilities
|
9,205 | 15,570 | ||||||
|
Stockholders' equity (deficit):
|
||||||||
|
Common stock, $0.001 par value; 250,000,000 shares authorized at September 30, 2010 and December 31, 2009; 40,304,235 and 40,159,466 shares issued including treasury shares at September 30, 2010 and December 31, 2009, respectively
|
40 | 40 | ||||||
|
Less: treasury common stock, 1,182,875 shares at September 30, 2010 and December 31, 2009, respectively, at cost
|
(53 | ) | (53 | ) | ||||
|
Additional paid-in-capital
|
103,544 | 102,504 | ||||||
|
Accumulated deficit
|
(109,777 | ) | (116,105 | ) | ||||
|
Total stockholders' equity (deficit)
|
(6,246 | ) | (13,614 | ) | ||||
|
Total liabilities and stockholders' equity (deficit)
|
$ | 2,959 | $ | 1,956 | ||||
|
Three Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
(unaudited)
|
||||||||
|
Net loss
|
$ | (1,500 | ) | $ | (1,885 | ) | ||
|
Other expense, net
|
20 | 126 | ||||||
|
Provision for (benefit from) income tax
|
(262 | ) | 16 | |||||
|
Depreciation
|
68 | 62 | ||||||
|
EBITDA
|
(1,674 | ) | (1,681 | ) | ||||
|
Stock-based compensation expense
|
409 | 429 | ||||||
|
Adjusted EBITDA
|
$ | (1,265 | ) | $ | (1,252 | ) | ||
|
Nine Months Ended September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
(unaudited)
|
||||||||
|
Net income (loss)
|
$ | 6,328 | $ | (2,451 | ) | |||
|
Other expense, net
|
37 | 358 | ||||||
|
Provision for (benefit from) income tax
|
(163 | ) | (37 | ) | ||||
|
Depreciation
|
181 | 182 | ||||||
|
EBITDA
|
6,383 | (1,948 | ) | |||||
|
Stock-based compensation expense
|
995 | 1,407 | ||||||
|
Adjusted EBITDA
|
$ | 7,378 | $ | (541 | ) | |||
|
Nine Months Ended September 30,
|
||||||||
|
|
2010
|
2009
|
||||||
|
(unaudited)
|
||||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net income (loss)
|
$ | 6,328 | $ | (2,451 | ) | |||
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation
|
181 | 182 | ||||||
|
Compensation on equity awards issued to consultants and employees
|
995 | 1,407 | ||||||
|
Provision for doubtful accounts
|
(4 | ) | (7 | ) | ||||
|
Changes in assets and liabilities:
|
||||||||
|
Accounts receivable
|
(525 | ) | 1,547 | |||||
|
Inventories
|
27 | 171 | ||||||
|
Prepaid expenses and other current assets
|
(392 | ) | 68 | |||||
|
Deferred settlement and patent licensing costs
|
- | 955 | ||||||
|
Other assets
|
(1 | ) | - | |||||
|
Accounts payable
|
(1 | ) | 98 | |||||
|
Deferred income from settlement and patent licensing and other
|
(22 | ) | (4,076 | ) | ||||
|
Deferred services revenue and customer deposits
|
(845 | ) | (2,459 | ) | ||||
|
Income taxes payable
|
57 | 17 | ||||||
|
Accrued liabilities and other
|
(304 | ) | 255 | |||||
|
Net cash provided by (used in) operating activities
|
5,494 | (4,293 | ) | |||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Purchase of property and equipment
|
(229 | ) | (47 | ) | ||||
|
Net cash used in investing activities
|
(229 | ) | (47 | ) | ||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Line of credit payments
|
(11,250 | ) | (5,049 | ) | ||||
|
Proceeds on line of credit
|
6,000 | 4,700 | ||||||
|
Net proceeds from issuance of common stock
|
45 | 173 | ||||||
|
Net cash used in financing activities
|
(5,205 | ) | (176 | ) | ||||
|
Net increase (decrease) in cash and cash equivalents
|
60 | (4,516 | ) | |||||
|
Cash and cash equivalents, beginning of year
|
294 | 4,898 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 354 | $ | 382 | ||||
|
Non-cash financing activities:
|
||||||||
|
Debt converted to equity
|
$ | - | $ | 2,940 | ||||